Non small cell lung cancer treatment with vinorelbine monochemotherapy: A phase II study

M. Clerici; S. Bretti; A. Celano; D. Panvini; A. Comandone; C. Casadio; G. Luporini; C. Bumma

Non small cell lung cancer treatment with vinorelbine monochemotherapy: A phase II study

M. Clerici, S. Bretti, A. Celano, D. Panvini, A. Comandone, C. Casadio, G. Luporini, C. Bumma

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Abstract

Non small cell lung cancer is one of the leading causes of death in the industrial countries and some 70% of patients have non surgically eradicable disease. Platinum based combined regimens can achieve 35-40% objective responses, but advanced age, low performance status and concurrent diseases can exclude up to 60% of patients from an adequate poliychemotherapy treatment.

Lingua originale	Inglese
pagine (da-a)	477-478
Numero di pagine	2
Rivista	Anticancer Research
Volume	15
Numero di pubblicazione	2
Stato di pubblicazione	Pubblicato - 1995
Pubblicato esternamente	Sì

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Altri file e collegamenti

Link to publication in Scopus

Cita questo

@article{a1621c3ba9f14ced977b5ea507dd5f3c,

title = "Non small cell lung cancer treatment with vinorelbine monochemotherapy: A phase II study",

abstract = "Non small cell lung cancer is one of the leading causes of death in the industrial countries and some 70% of patients have non surgically eradicable disease. Platinum based combined regimens can achieve 35-40% objective responses, but advanced age, low performance status and concurrent diseases can exclude up to 60% of patients from an adequate poliychemotherapy treatment.",

keywords = "Monochemotherapy, Non small cell lung cancer, Vinorelbine",

author = "M. Clerici and S. Bretti and A. Celano and D. Panvini and A. Comandone and C. Casadio and G. Luporini and C. Bumma",

year = "1995",

language = "English",

volume = "15",

pages = "477--478",

journal = "Anticancer Research",

issn = "0250-7005",

publisher = "International Institute of Anticancer Research",

number = "2",

}

TY - JOUR

T1 - Non small cell lung cancer treatment with vinorelbine monochemotherapy

T2 - A phase II study

AU - Clerici, M.

AU - Bretti, S.

AU - Celano, A.

AU - Panvini, D.

AU - Comandone, A.

AU - Casadio, C.

AU - Luporini, G.

AU - Bumma, C.

PY - 1995

Y1 - 1995

N2 - Non small cell lung cancer is one of the leading causes of death in the industrial countries and some 70% of patients have non surgically eradicable disease. Platinum based combined regimens can achieve 35-40% objective responses, but advanced age, low performance status and concurrent diseases can exclude up to 60% of patients from an adequate poliychemotherapy treatment.

AB - Non small cell lung cancer is one of the leading causes of death in the industrial countries and some 70% of patients have non surgically eradicable disease. Platinum based combined regimens can achieve 35-40% objective responses, but advanced age, low performance status and concurrent diseases can exclude up to 60% of patients from an adequate poliychemotherapy treatment.

KW - Monochemotherapy

KW - Non small cell lung cancer

KW - Vinorelbine

UR - http://www.scopus.com/inward/record.url?scp=0029018135&partnerID=8YFLogxK

M3 - Article

SN - 0250-7005

VL - 15

SP - 477

EP - 478

JO - Anticancer Research

JF - Anticancer Research

IS - 2

ER -

Non small cell lung cancer treatment with vinorelbine monochemotherapy: A phase II study

Abstract

OSS delle Nazioni Unite

Altri file e collegamenti

Fingerprint

Cita questo